February 14, 2022: Given the lack of evidence of a more meaningful benefit, we support the “C” grade recommendation that clinicians make decisions for these individual patients about whether to offer or refer them to behavioral counseling.
Read More »Tag: cardiovascular disease
NCHR Comments on USPSTF’s Draft Recommendation on Aspirin Use to Prevent Cardiovascular Disease
November 8, 2021. Based on the data, we strongly support the “C” grade recommendation for patients 40 to 59 years old with a 10% or more risk of developing CVD, as well as the “D” grade recommendation for patients 60 and older. However, we urge the USPSTF to include additional information to their recommendation.
Read More »NCHR’s Comments on USPSTF’s Draft Research Plan for Cardiovascular Disease Prevention
June 8, 2020. We support the US Preventive Services Task Force’s efforts to update recommendations based on new scientific evidence.
Read More »NCHR’s Comments on USPSTF’s Draft Research Plan for Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Risk Factors
We support USPSTF’s efforts to update existing recommendations based on new research. Although we applaud many aspects of the draft research plan, it would benefit from including several additional analyses.
Read More »